Forms 3, 4 & 5
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,171 | $117.58 | 17,130 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 2,242 | $243.73 | 14,888 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,423 | $135.78 | 17,311 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 1,819 | $243.73 | 15,492 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,183 | $163.47 | 17,675 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 1,786 | $243.73 | 15,889 |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,171 | -- | -- |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,423 | -- | -- |
| Feb 23, 2026 |
Director
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,183 | -- | -- |
| Jan 02, 2026 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 306 | $195.88 | 8,397 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.